Item 1. Legal Proceedings
ITEM
1. Legal Proceedings
We
are subject to the legal proceedings and claims discussed below as well as certain other legal proceedings and claims that have not been
fully resolved and that have arisen in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings
individually and in the aggregate and evaluates potential losses on such litigation if the amount of the loss is estimable and the loss
is probable. However, the outcome of legal proceedings and claims brought against the Company is subject to significant uncertainty.
Although management considers the likelihood of such an outcome to be remote, if one or more of these legal matters were resolved against
the Company for amounts in excess of management’s expectations, the Company’s financial statements for that reporting period
could be materially adversely affected. The Company settled certain matters subsequent to year end that did not individually or in the
aggregate have a material impact on the Company’s financial condition or operating results.
In
2017, the Company’s former COO was awarded approximately $238,000 in accrued salary and related charges by the California labor
board. The Company believes that this award does not reflect the amount owed which is significantly lower and is exploring all its options
and available remedies and is working toward an offer to settle this matter.
The
Company is presently engaged in a dispute with one of its former directors, Robert Kopple, relating to approximately $11.5 million (representing
approximately $5.4 million loaned to the Company over the course of 2013 to 2016; approximately $170,000 Mr. Kopple claims to have advanced
or paid to third parties on Aura’s behalf; and approximately $5.9 million Mr. Kopple claims to be owed for interest, loan fees
and late payment feess) and approximately 3.33 million warrants which Mr. Kopple claims to be owed to him and his affiliates by the Company.
In July 2017, Mr. Kopple filed suit against the Company as well as against current director Mr. Diaz-Verson and former directors Mr.
Breslow and Mr. Howsmon, as well as Mr. Gagerman,
our former CEO and a former director in connection with these allegations. In 2018, the Court sustained demurrers by Mr. Diaz-Verson,
Mr. Breslow, Mr. Howsmon and Mr. Gagerman, and as a result of these successful demurrers, all four of these defendants have been dismissed
from the suit. While the Company believes that it has certain valid defenses in these matters, the Company is currently in settlement
discussions with Mr. Kopple. However, to-date, no settlement has been reached in large part because Mr. Kopple continues to demand
that as part of any such settlement, he receive unilateral control over significant aspects of the Company’s financial and management
functions such as, but not limited to, the right to unilaterally direct the Company’s ordinary business expenditures and requiring
the Company to seek his approval for the hiring of nearly all personnel, all to the exclusion of the Company’s management team
and stockholder-elected Board of Directors. The Company believes that allowing Mr. Kopple such level of operational control over the
Company without any accountability would be highly detrimental to the Company and is incompatible with the Board of Directors’
duties to shareholders and creditors as a whole.
On
March 26, 2019, various stockholders of the Company controlling a combined total of more than 27.5 million shares delivered a signed
written consent to the Company removing Ronald Buschur as a member of the Company’s Board and electing Cipora Lavut as a
director of the Company. On March 27, 2019, those same stockholders delivered a further signed written consent to the Company
removing William Anderson and Si Ryong Yu as members of the Company’s Board and electing Robert Lempert and David Mann as
directors of the Company. These written consents represented a majority of the outstanding shares of the Company’s common
stock as of March 26, 2019 and March 27, 2019, respectively. Because of Aura’s refusal to recognize the legal
effectiveness of the consents, on April 8, 2019 the stockholders filed suit in the Court of Chancery of the State of Delaware
pursuant to Section 225 of the Delaware General Corporations Law, seeking an order confirming the validity of the consents and
declaring that Aura’s Board consists of Ms. Lavut, Mr. Mann, Dr. Lempert, Mr. Douglas and
Mr. Diaz-Versón, Jr. On July 8, 2019 the Court of Chancery entered final judgment in favor of the stockholder
plaintiffs, confirming that (a) Ronald Buschur, Si Ryong Yu and William Anderson had been validly removed by the holders of a
majority of the Company’s outstanding stock acting by written consent (b) Ms. Lavut, Mr. Mann and Dr. Lempert had been validly
elected by the holders of a majority of the Company’s outstanding stock acting by written consent, and (c) the Company’s
Board of Directors validly consists of Cipora Lavut, David Mann, Robert Lempert, Gary Douglas and Salvador Diaz-Versón, Jr.
As a result of prior management’s unsuccessful opposition to this stockholders’ action filed in the Court of Chancery,
such stockholders may be potentially entitled to recoup their litigation costs from the Company under Delaware’s corporate
benefit doctrine and/or other legal provisions. To-date, no final determination has been made as to the amount of recoupment, if
any, to which such stockholders may be entitled.
ITEM
1A. Risk Factors
In
addition to the other information set forth in this report, you should carefully consider the risk factors disclosed in Item 1A, “Risk
Factors,” of the Company’s Fiscal 2021 Annual Report on Form 10-K issued on June 1, 2021 .
20
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.